hmpl-453
Showing 1 - 6 of 6
Intrahepatic Cholangiocarcinoma Trial in Shanghai (HMPL-453, Rabeprazole)
Active, not recruiting
- Intrahepatic Cholangiocarcinoma
- HMPL-453
- Rabeprazole
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
Jun 24, 2023
Solid Tumor Trial in Beijing (HMPL-453, gemcitabine and cisplatin, toripalimab)
Recruiting
- Solid Tumor
- HMPL-453
- +3 more
-
Beijing, ChinaChinese PLA General Hospital
Mar 4, 2022
Advanced Malignant Mesothelioma Trial in Shanghai (HMPL-453)
Recruiting
- Advanced Malignant Mesothelioma
- HMPL-453
-
Shanghai, ChinaShanghai Chest Hospital
Jun 12, 2020
Advanced Bile Duct Cancer Trial (HMPL-453)
Not yet recruiting
- Advanced Bile Duct Cancer
- HMPL-453
- (no location specified)
Jun 12, 2020
Solid Tumor, Adult Trial in Beijing, Guangzhou (HMPL-453)
Unknown status
- Solid Tumor, Adult
- HMPL-453
-
Beijing, Beijing, China
- +1 more
Feb 12, 2020
Solid Tumor Trial in Sydney, Frankston, Melbourne (HMPL-453)
Terminated
- Solid Tumor
- HMPL-453
-
Sydney, New South Wales, Australia
- +3 more
Nov 19, 2018